Exosomal microRNA Therapy for Non-Small-Cell Lung Cancer
With the progress of molecular diagnosis research on non-small cell lung cancer (NSCLC) cells, four identified categories of microRNAs have been found to be related to disease diagnosis, diagnosis of treatment resistance, prediction of prognosis, and drugs for treatment. To date, nine target mRNA/si...
Main Authors: | Jibing Chen MD, Fasheng Wu MD, Encun Hou MD, Jianying Zeng MD, Fujun Li MD, Hongjun Gao MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-11-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/15330338231210731 |
Similar Items
-
Exosomal microRNA-Based therapies for skin diseases
by: Chen Jibing, et al.
Published: (2024-03-01) -
Choice of samples in extracellular microRNA research: Which fraction is better- exosomal or nonexosomal?
by: Md Mahmodul Hasan Sohel
Published: (2018-04-01) -
The role of exosomes and exosomal microRNA in diabetic cardiomyopathy
by: Shiyu Gao, et al.
Published: (2024-01-01) -
Circulating exosomes from patients with peripheral artery disease influence vascular cell migration and contain distinct microRNA cargo
by: Thomas A. Sorrentino, MD, et al.
Published: (2020-01-01) -
Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer
by: Dong Ha Kim, et al.
Published: (2023-09-01)